A phase 2 study supports the use of a microRNA eye drop for patients with corneal damage or dry eye disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback